Zobrazeno 1 - 10
of 725
pro vyhledávání: '"Jin-Seok Ahn"'
Autor:
Youngji Kwak, Sung Yoon Jang, Joon Young Choi, Hyunjun Lee, Dong Seung Shin, Yeon Hee Park, Ji-Yeon Kim, Jin-Seok Ahn, Byung Joo Chae, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Jai Min Ryu
Publikováno v:
Cancers, Vol 15, Iss 13, p 3435 (2023)
Background: Although estrogen receptor (ER) expression levels affect the prognosis of breast cancer, studies about progesterone receptor (PR) expression levels are insufficient, especially in young breast cancer (YBC). The purpose of this study was t
Externí odkaz:
https://doaj.org/article/1b78ada851134ce0807f2634870164d9
Autor:
Mi Hwa Heo, Hee Kyung Kim, Hansang Lee, Ji-Yeon Kim, Jin-Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Publikováno v:
The Korean Journal of Internal Medicine, Vol 34, Iss 5, Pp 1100-1106 (2019)
Background/Aims We conducted a retrospective analysis of the clinical activity of fulvestrant in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) previously t
Externí odkaz:
https://doaj.org/article/4ebabb5d2fc645c197cade781d4e50ad
Autor:
Soo-Mee Bang MD, PhD, Jin-Hyoung Kang MD, PhD, Min Hee Hong MD, PhD, Jin-Seok Ahn MD, PhD, So Yeon Oh MD, PhD, Jin Ho Baek MD, PhD, Yoon Ji Choi MD, PhD, Seong Hoon Shin MD, PhD, Young-Joo Kim MSN, Ha-Yeong Gil MS, Hyung-Eun Park MD, Juneyoung Lee PhD, Eun-Lyeong Park MS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
This study assessed epidemiologic data and clinical outcomes, including venous thromboembolism (VTE) recurrence and bleeding events, in patients with cancer-associated VTE, and assessed factors associated with clinical outcomes. Data were extracted f
Externí odkaz:
https://doaj.org/article/4cf4a402f661465db74f5cd782853cab
Autor:
Kyung-Hee Lee, Tae Won Kim, Jung-Hun Kang, Jin-Soo Kim, Jin-Seok Ahn, Sun-Young Kim, Hwan-Jung Yun, Young-Jun Eum, Sung Ae Koh, Min Kyoung Kim, Yong Sang Hong, Jeong Eun Kim, Gyeong-Won Lee
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-9 (2017)
Abstract Background Controlled-release oxycodone/naloxone (OXN-CR) maintains the effect of opioid-induced analgesia through oxycodone while reducing the occurrence rate of opioid-induced constipation through naloxone. The present study was designed t
Externí odkaz:
https://doaj.org/article/872be79163264738b6f318f7b9f1cd0a
Autor:
ji-Yeon Kim, Jeehyun Kim, Hae Hyun Jung, eun Yoon Cho, Yeon Hee Park, Jin Seok Ahn, Kyoung-Mee Kim, Young-Hyuck Im
Publikováno v:
Cancer Research. 83:P2-20
Introduction Recent advances in breast cancer treatment strategies have improved survival outcomes in metastatic breast cancer (mBC). Targeting immune checkpoint, especially programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1), has made a brea
Autor:
Hyun Ae, Jung, Miso, Kim, Hae Su, Kim, Joo-Hang, Kim, Yoon Hee, Choi, Jinhyun, Cho, Ji Hyun, Park, Keon Uk, Park, Bo Mi, Ku, Sehhoon, Park, Jong-Mu, Sun, Se-Hoon, Lee, Jin Seok, Ahn, Keunchil, Park, Myung-Ju, Ahn
Publikováno v:
Journal of Thoracic Oncology. 18:223-231
Thymic epithelial tumors (TETs) are rare but are the most common tumors of the anterior mediastinum. Platinum-based combination chemotherapy is the standard of care for such tumors and is associated with a 50% to 90% objective response rate (ORR) in
Autor:
Youngkyung Jeon, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Publikováno v:
Cancer Research & Treatment; Jan2024, Vol. 56 Issue 1, p61-69, 9p
Autor:
Sang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, Dongryul Oh, Kyungmi Yang, Nalee Kim, Jong-Mu Sun, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Jae Myoung Noh
Publikováno v:
Radiation Oncology Journal; Dec2023, Vol. 41 Issue 4, p274-282, 9p
Autor:
Hye Ryeon Kim, Hyunji Jo, Hongsik Kim, Joohyun Hong, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Jin-Seok Ahn, Myung-Ju Ahn
Publikováno v:
Cancer Research and Treatment. 55:344-349
Leptomeningeal metastasis (LM) is a rare but fatal clinical condition with a short survival time. The incidence of LM from epidermal growth factor receptor mutant (EGFRm) non–small cell lung cancer (NSCLC) has increased due to the limited efficacy
Autor:
Bo Mi Ku, Sungwon Park, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yoon-La Choi, Myung-Ju Ahn
Publikováno v:
Precision and Future Medicine. 6:233-242
Purpose: Mesenchymal-epithelial transition tyrosine kinase receptor (MET) amplification is one of the common acquired resistance mechanisms to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). To evaluate the usefulness of scre